advertisement
 |
|
Top Stories
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
/ read more /
The government is exploring terms by which the UK could still be part of EMA after its departure from the EU, Theresa May said in a key speech on Brexit.
/ read more /
|
|
|
advertisement
 |
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
|
advertisement
 |
|
Industry News
The company is recalling three lots of Hydromorphone HCl Injection USP CII 10 mg/mL, 1 mL in 2 mL Single Dose Vials because of possibly empty or cracked vials.
/ read more /
JLL, a real estate and investment management firm, recently released a new report on three trends shaping labs for the future of life sciences R&D.
/ read more /
More Industry News
|
|
|
Supplier News
Catalent completes $4.6 million expansion at Singapore clinical supply facility and marks 20 years in the region.
/ read more /
With minimal damage to its manufacturing plant in Humacao, Puerto Rico, Colorcon has been able to restore full operations.
/ read more /
More Supplier News
|
|
|
Bio/Pharma News
The companies will work together to develop prescription digital therapeutics for patients with schizophrenia and multiple sclerosis.
/ read more /
The companies will join forces to develop next-generation ex vivo cell therapies in oncology.
/ read more /
More Bio/Pharma News
|
|
|
Regulatory News
The agency has approved a new HIV treatment for patients with "limited treatment options".
/ read more /
The upcoming serialization deadline and the United Kingdom's departure from the European Union could result in supply bottlenecks.
/ read more /
More Regulatory News
|
|
|
advertisement
The 2018 PDA Annual Meeting will deliver the same high-quality content attendees expect in a NEW meeting format that starts on Monday afternoon. Delve into the future of bio/pharmaceutical manufacturing with the latest updates on the end user/patient perspective, innovative manufacturing strategies, and disruptive technologies. The industry's increased use of big data, artificial intelligence, and robotics will also be explored.  Learn more and register today! |
|
|
|
Outsourcing
Research suggests that working with a single contract partner can reduce development time and improve economics.
/ read more /
|
|
|
|
Analytics
Joe DiMasi, director of economic analysis and research associate professor, Tufts Center for the Study of Drug Development (CSDD), discussed research into the impacts of working with single source contractors with Pharmaceutical Technology.
/ read more /
|
|
|
|
Standards & Regulations
CRLs put the brakes on drug development and damage corporate reputation and stock prices. Upfront investment and better sponsor oversight are ways to prevent them.
/ read more /
|
|
|
|
Manufacturing
Materials used in the seals of split butterfly valves for aseptic pharmaceutical manufacturing should be chosen carefully.
/ read more /
|
|
|
Events
March 12–14, 2018
March 12–14, 2018
March 13–14, 2018
more events |
|
|
eBOOKS
 |
Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible. |
|
|
|
|
|
